AVTX

Neutral

Avoro holds 1.41M shares in Avalo Therapeutics (NASDAQ: AVTX)

Avoro Capital Advisors LLC and Behzad Aghazadeh have reported a passive beneficial ownership of 1.41 million shares, or 5.75%, in Avalo Therapeutics (...

Stock Titan 5 days ago 0

Neutral

Earnings Flash (AVTX) Avalo Therapeutics Posts Q1 Loss $0.98 a Share, vs. FactSet Est of $1.03 Loss

Avalo Therapeutics (AVTX) reported a Q1 loss of $0.98 per share, which is better than the FactSet estimate of a $1.03 loss per share. The company is a...

www.marketscreener.com 1 week ago 0

Neutral

Avalo Therapeutics, Inc. 1Q 2026: Revenue ($19.7M), Net income ($19.63M), EPS ($0.98) — 10-Q Summary

Avalo Therapeutics, Inc. reported its first-quarter 2026 results, showing increased comprehensive and net losses compared to the previous year. This w...

TradingView 1 week ago 0

Bullish

Avalo Therapeutics Stock Jumps 33% In Pre-Market Session: Here's Why

Avalo Therapeutics (NASDAQ:AVTX) saw its stock jump 33% in pre-market trading after announcing positive topline data from its Phase 2 LOTUS trial for ...

Benzinga 2 weeks ago 0